NUV-868 as Monotherapy and in Combination With Olaparib or Enzalutamide in Adult Patients With Advanced Solid Tumors

Clinical Trials, Metastatic Castration Resistant Prostate Cancer (MCRPC)

— PHENTrials.com Increasing Participation in Prostate Cancer Clinical Trials to Save Lives

NCT Number: NCT05252390
Phase: Phase 1|Phase 2
Trial Summary: NUV-868-01 is a first-in-human, open-label, Phase 1/2 dose escalation and expansion study in patients with advanced solid tumors. The Phase 1 and 1b portions include patients with – clinicaltrials.gov for more information and locations
Clinicaltrials.gov
Trial Sponsor(s): Nuvation Bio Inc.
Acronym:

Pin It on Pinterest